Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Biochimica Et Biophysica Acta|September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancerJames A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.
Oncotarget|December 22, 2016
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A McCubrey, Timothy L Fitzgerald, Li V Yang, et al.
Oncogene|March 12, 2008
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitorsL S Steelman, P M Navolanic, M L Sokolosky, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 9, 2012
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategiesMaria Rosaria Ricciardi, Maria Cristina Scerpa, Paola Bergamo, et al.
Oncotarget|September 26, 2012
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy responseJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Aging|June 15, 2017
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAsJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Oncotarget|October 23, 2012
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistanceJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 26